Entera Bio (ENTX) Return on Equity [ROE] (2021 - 2026)
Entera Bio (ENTX) posted Return on Equity [ROE] of -160.76% for Q2 2026, down 102.84 percentage points from -57.92% a year earlier and down 55.37 percentage points from the prior quarter.
Entera Bio (ENTX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Entera Bio's Return on Equity [ROE] came in at -108.01%, down 4.68 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -2.62 percentage points (FY2020 to FY2025).
- In prior years, Entera Bio's Return on Equity [ROE] was -103.34% in FY2024 (-23.04 pp), -80.30% in FY2023 (-4.12 pp), -76.17% in FY2022 (+4.87 pp) and -81.04% in FY2021 (+24.35 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2021.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +2.47 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 56.81 percentage points; the weakest was Q2 2026, with a drop of 102.84 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -105.40% (Q1 2026), -81.60% (Q4 2025) and -67.03% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Entera Bio | 143.43 Mn | 112.31 Mn | - | -160.76% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -160.76% |
| Mar 31, 2026 | -105.40% |
| Dec 31, 2025 | -81.60% |
| Sep 30, 2025 | -67.03% |
| Jun 30, 2025 | -57.92% |
| Mar 31, 2025 | -73.87% |
| Dec 31, 2024 | -132.69% |
| Sep 30, 2024 | -123.84% |
| Jun 30, 2024 | -99.29% |
| Mar 31, 2024 | -91.03% |
| Dec 31, 2023 | -106.95% |
| Sep 30, 2023 | -137.25% |
| Jun 30, 2023 | -115.96% |
| Mar 31, 2023 | -105.13% |
| Dec 31, 2022 | -100.29% |
| Sep 30, 2022 | -89.52% |
| Jun 30, 2022 | -77.18% |
| Mar 31, 2022 | -76.82% |
| Dec 31, 2021 | -60.46% |
| Sep 30, 2021 | -52.72% |
Entera Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();